Vogenx Inc. (VOGX) Investment Research Dashboard
About Vogenx Inc. (VOGX) stock analysis
Get live VOGX stock price $13.01, comprehensive Vogenx Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time VOGX stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Vogenx is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia (PBH) an...
Company Information
- CEO
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- N/A
Contact Information
- Website
- https://www.vogenx.com
- Address
- 3901 Barrett Drive, Suite 300
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Listed on major US exchange (NASDAQ) providing liquidity and transparency
✓ Lower volatility stock (Beta: 0.00) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Vogenx Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for large-cap equities
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Vogenx Inc.
- ⚠Investors should consider how Vogenx Inc. fits within their overall portfolio allocation
Beta
0.00
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
75/100 ⭐⭐⭐⭐⭐
- Overall
- -0.6%
- NYSE
- -0.8%
- NASDAQ
- -0.4%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Energy | -0.5% | +4.6% | +2.9% | 18.9 | 84/100⭐⭐⭐⭐⭐ |
| Financial Services | +0.1% | -0.2% | +4.7% | 19.5 | 77/100⭐⭐⭐⭐⭐ |
| Healthcare | -0.6% | +2.1% | +2.9% | 23.5 | 75/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | +0.5% | +2.7% | +2.6% | 29.1 | 64/100⭐⭐⭐⭐ |
| Communication Services | +1.1% | +0.8% | +0.9% | 20.9 | 57/100⭐⭐⭐⭐ |
| Industrials | -0.3% | +2.9% | +1.0% | 31.5 | 52/100⭐⭐⭐ |
| Technology | +1.2% | -0.6% | +1.2% | 45.3 | 41/100⭐⭐⭐ |
| Real Estate | +0.4% | +0.7% | -1.9% | 27.8 | 34/100⭐⭐ |
| Basic Materials | +0.0% | -0.5% | -0.7% | 25.0 | 32/100⭐⭐ |
| Consumer Cyclical | +0.5% | +0.5% | -2.0% | 45.5 | 21/100⭐ |
| Utilities | -0.7% | -0.7% | -8.8% | 24.5 | 12/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-08-13.